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A B S T R A C T
Obesity is associated with inflammation and oxidative stress. Bioactive compounds can decrease obesity-related
disorders by their antioxidant and anti-inflammatory actions. Wistar rats were fed with a high-fat diet during
14 weeks and received 100mg of wine pomace product (WP)/kg body weight, from the 1st week or from the 7th
week and standard diet fed rats were included. Food intake, body weight, blood pressure and plasma glucose,
cholesterol and triglyceride were weekly measured. Antioxidant and lipid liver status, fat, adipocyte size, plasma
interleukins and microbiota were also determined at 14th week. The results showed a significant reduction of
body weight and abdominal fat area, lower blood glucose, decreased liver weight and lipids deposition with
increased antioxidant status, lower adipocyte size and increased Lactobacillus spp./Bacteroides spp. ratio.
Therefore, wine pomace product reduced obesity-related disorders by amelioration of inflammation and oxi-
dative stress and by microbiota regulation suggesting potential preventive clinical benefits.
1. Introduction
Obesity is a multifactorial and inflammatory disease that is asso-
ciated to several health disorders including hypertension, dyslipidemia,
insulin resistance, type 2 diabetes, cancer and cardiovascular compli-
cations. It is characterized by an excess of adipose tissue which occurs
through adipocyte hypertrophy and hyperplasia (Siriwardhana et al.,
2013). Adipose tissue has an active metabolism and endocrine function
that control the energy balance and homeostasis through adipocyte-
derived pro- and anti-inflammatory cytokines (adipokines). Therefore,
the prevalence of pro-inflammatory adipokines conduces to a systemic
inflammation and obesity-relates disorders (Wang et al., 2014). Other
factor that also contributes to the pathogenesis of the obesity is the
oxidative stress by stimulating the deposition of adipose tissue and al-
tering food intake (Manna & Jain, 2015). In this sense, the combination
of oxidative stress, dysregulation of adipokines and other factors asso-
ciated to obesity (i.e. insulin resistance, lipotoxicity, gut microbiota
alterations) are responsible of lipid accumulation in the hepatocytes
leading to hepatocyte injury, fibrosis, and chronic liver disease
(Polyzos, Kountouras, & Mantzoros, 2019). It is known the role of the
reactive oxygen species (ROS) in the development of the obesity
(Lechuga-Sancho et al., 2018; Rani, Deep, Singh, Palle, & Yadav, 2016).
Thus, antioxidant therapy could be an important strategy to deal with
obesity-related disorders.
Wine pomace products, contains abundant bioactive compounds,
including fiber and polyphenols such as phenolic acids, resveratrol,
catechins and anthocyanidins which has been suggested to have several
beneficial effects. Consumption of foods rich in these bioactive com-
pounds has been accepted to decrease inflammation through their anti-
inflammatory action (Maleki, Crespo, & Cabanillas, 2019; Siriwardhana
et al., 2013). Dietary fiber has potential effect on satiety and reduces
the absorption of carbohydrates and triglycerides, thus leading a re-
duction of cardiovascular diseases (Baboota et al., 2013; Lattimer &
Haub, 2010). Del Pino-García, Gerardi et al. (2016) associated an in-
creased butyrate production from the intestinal metabolism of wine
pomace fibers with an increase in plasma insulin and reduction of the
blood glucose in diabetic rats. In another hand, there are strong evi-
dence that dietary polyphenols increase thermogenesis and energy
consumption while decreasing inflammation and oxidative stress with
possible weight loss and preventing obesity-related disorders (Wang
et al., 2014). Wang et al. (2014) proposed that polyphenols prevent
obesity through several mechanisms including reduction of food intake,
decreased lipogenesis and increased lipolysis, inhibition of adipocyte
differentiation and proliferation, and attenuation of pro-inflammatory
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responses and oxidative stress. There are several signaling pathways
associated with the polyphenols actions in the adipose tissue including
AMPK, MAPK, NF-κB, PPARα/γ and TLR2/4 (Siriwardhana et al.,
2013). Some polyphenols such as resveratrol or epigallocatechin gallate
(EGCG) reduce the PPARγ expression inhibiting the adipocyte differ-
entiation and proliferation. Anthocyanidins decrease fat accumulation
in adipocytes through activating AMPK that converts adipocytes into
lipid-oxidizing cells and contributes to the regulation of lipolysis and
lipogenesis (Wei et al., 2011).
Changes in the gut microbiota are other factor involved in the de-
velopment of obesity-disorders. Gut microbiota is involved in the reg-
ulation of metabolic function, development of low-grade inflammation
and regulation of energy balance. The microbiota composition can
modifies the digestibility and absorption of dietary undigested poly-
saccharides, decreases liver fatty acid oxidation by suppressing the
adenosine monophosphate kinase (AMPK) and contributes in the sys-
temic inflammation observed in obesity (Al-Assal et al., 2018). Diet
polyphenols can alter the gut microbiota community, resulting in a
greater abundance of beneficial bacteria, and a consequent increase in
bioavailability (Ozdal et al., 2016). Moreover, there is a mutual re-
lationship between gut microbiota and bioactive compounds (fiber,
polyphenols) that increases the bioavailability of phenolic compounds
and provides increased health benefits.
The present study was designed to evaluate the potential beneficial
effect of a red wine pomace product (WP) against obesity-related dis-
orders. Wistar rats fed with high-fat diet were used as model of obesity
and WP was administered into the diet at two times: from the first week
or from the seven week, in order to determine whether the WP prevents
the obesity development or ameliorates the disorders of an established
obesity.
2. Materials and methods
2.1. Chemicals and reagents
LASQCdiet® Rod14-H was obtained from Sodispan (Madrid, Spain).
D12451 Rodent Diet with 45 kcal % Fat was purchased from
Brogaarden (Lynge, Danmark). Cholesterol and Triglyceride Kits were
acquired from BioSystems S.A. (Barcelona, Spain). 2,4-dini-
trophenylhydrazine (DNFH), phosphoric acid solution (H3PO4), so-
dium pyruvate, 1,1,3,3-tetramethoxypropane (TMP), 2-thiobarbituric
acid (TBA), 2-vinylpyridine and cOmplete™ Protease Inhibitor Cocktail
were obtained from Sigma-Aldrich, Co. (St. Louis, MO, USA).
Trichloroacetic acid (TCA) was purchased from Panreac Quimica S.L.U.
(Barcelona, Spain). Dimethylsulphoxide (DMSO) and phosphate buf-
fered saline (PBS) tablets were purchased from Merck Millipore, Co.
(Darmstadt, Germany). QIAmp Mini DNA kit was obtained from Qiagen
(West Sussex, UK). iQ™ SYBR® Green Supermix was obtained from Bio-
rad Laboratories (Hercules, CA, USA). 2.4.6-Tri(2-pyridyl)-5-triazine
(TPTZ) and guanidine hydrochloride were purchased from Acros
Organics. Proteinase K 20mg/ml were acquired from ThermoFisher
Scientific (Massachusetts, USA). Enzyme-Linked Inmunoabsorbent
Assay (ELISA) kits for Tumor Necrosis Factor-Alpha (TNF-α),
Interleukin 1 Beta (IL1β) and Interleukin 10 (IL10) were purchased
from Cloud-Clone Corp. (Houston, USA).
2.2. Red wine pomace product (WP)
Red wine pomace-derived product from the vinification of Vitis vi-
nifera L. cv. Tempranillo was prepared at the University of Burgos ac-
cording to a previously described method (González-SanJosé, García-
Lomillo, Del Pino-García, Muñiz-Rodríguez, & Rivero-Pérez, 2015).
This product was obtained from seedless red wine pomace (WP) and its
main characteristics and composition (dietary fiber, fat, protein, mi-
nerals and phenolic classes) have been determined previously (Gerardi,
Cavia-Saiz, Rivero-Pérez, González-SanJosé, & Muñiz, 2019) and are
summarized in Supplementary Table 1.
2.3. Animals
Experimentation with animals was approved by the Ethics
Committee for Experimental Animal Care at the University of Burgos
and was carried out in accordance with the Spanish and European laws
(Royal Decree 53/2013 of the Spanish Ministry of agriculture, Food and
Environment and Ministry of Economy and Competitiveness, and
European Directive 2010/63/EU). Male Wistar rats (Rattus norvegicus;
n= 25; age, 8 weeks; weight: 312 ± 27 g) were obtained from the
Animal Research and Welfare Service of Valladolid (SIBA, Valladolid,
Spain). The room was maintained at 21 ± 2 °C and humidity at
40 ± 10%, with a 12:12-h light:dark cycle and free access to food
(LASQCdiet® Rod14-H, Sodispan, Madrid, Spain) and water. The ani-
mals were subjected to human manipulation during the weeks before
the experiments for acclimatization. All procedures were designed to
limit the number of animals used.
2.4. Experimental animal groups
Animals were randomly divided into two groups: control and high-
fat diet (HF). Rats in the control group were fed standard chow diet (6%
kcal fat) and rats in HF group received a high-fat diet (45% kcal fat).
Two experimental protocols were development (Supplementary Fig. 1).
The animals were randomly divides into 4 groups:
– Group 1 (SD): Rats were fed with STANDARD DIET (LASQCdiet®
Rod14-H, Sodispan) from week 1 to 14 of the experiment (SD,
18–22 g/d, n=5) and supplemented daily with 5 g of low-fat yo-
gurt.
– Group 2 (HF): Rats were fed with HIGH FAT DIET (Rodent Diet with
45 kcal% Fat D12451, Research Diets) from week 1 to 14 of the
experiment (HF, 18–22 g/d, n= 5) and supplemented daily with 5 g
of low-fat yogurt.
– Group 3 (HF+WP1w): Rats were fed with HIGH FAT DIET (Rodent
Diet with 45 kcal% Fat D12451, Research Diets) and 100mg of WP/
kg/d from week 1 to 14 of the experiment (HF+WP, n=5) dis-
solved in 5 g of low-fat yogurt.
– Group 4 (HF+WP7w): Rats were fed with HIGH FAT DIET (Rodent
Diet with 45 kcal % Fat D12451, Research Diets) from week 1 to 14
of the experiment (18–22 g/d) and received 100mg of WP/kg/d
from week 7 to 14 (HF+WP7w, n= 5) dissolved in 5 g of low-fat
yogurt.
The composition of the different types of diet were evaluated and
showed in Supplementary Table 2. The dosage of WP evaluated in the
present work was selected by the authors according to previous studies
(Del Pino-García, Rivero-Pérez, González-SanJosé, Croft, & Muñiz,
2017; Gerardi, Cavia-Saiz, Rivero-Pérez, González-SanJosé, & Muñiz,
2020). The human equivalent dose (HED) was calculated and the rat
intake of 100mg/kg/d of WP equals to 1 g/d in human.
2.5. Weekly measurements
Food and water intake was registered 3 times a week and the ani-
mals were weighted once a week. Systolic blood pressure and blood
glucose was also assessed weekly. For systolic blood pressure mea-
surement, rats were placed into restrained cage and 10 systolic blood
pressure determinations were assessed by the tail-cuff method using a
LE 5001 Pressure Meter (PanLab Harvard Apparatus, Barcelona, Spain)
and a LE 160R Pulse Transducer for Rat (PanLab Harvard Apparatus,
Barcelona, Spain).
Once a week, blood samples were taken by lateral saphenous ve-
nepuncture with a 23G needle and held in vacutainer tubes containing
sodium/lithium heparin as an anticoagulant. One drop of blood was
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used for glucose determination using a glucometer (Ascensia Breeze2,
Bayer). Then, Vacutainer tubes containing the blood samples were
centrifuged at 1500 g for 10min to recover the plasma. Plasma samples
were stored at −80 °C until analysis. The volume of blood taken for
each rat was never more than 1ml as per the NC3Rs recommendations
(4.4% blood volume removed) (Diehl et al., 2001). Plasma cholesterol
and triglyceride were measurement in the plasma samples by kits
(BioSystems S.A., Barcelona, Spain).
2.6. Final measurements
At week 15 a combined ketamine/xylazine anesthetic (80mg ke-
tamine/kg and 20mg xylazine/kg) was administrated to rats by in-
traperitoneal injection. Then, blood samples were collected in sodium/
lithium heparine-vacutainer tubes by cardiac puncture and im-
mediately, rats were euthanized by intra-cardiac injection of Sodium
Pentobarbital (300mg/kg). Blood samples were centrifuged at 1500g
for 10min to recover the plasma. Plasma cholesterol and triglyceride
were measurement in the plasma samples by kits following the manu-
facturer‘s instructions (BioSystems S.A., Barcelona, Spain). Pancreas,
liver, kidney, hearth and intestine were collect and weighted from all
euthanized rats. Visceral fat tissue (thoracic, mesenteric, perirenal and
gonadal) were also collected, classified and weighted. All weights are
normalized with the length of the femur an expressed as mg/mm.
Caecal content was collected and, as all tissues, frozen at −80 °C.
2.6.1. Liver homogenization and lipids measurement
Liver homogenates were obtained by homogenization of 500mg of
liver in cold 50mM potassium phosphate buffer containing protease
inhibitor cocktail. The homogenates were centrifuged at 10,000g for
15min at 4 °C and the supernatant were collected. Proteins were de-
termined in the homogenate by Lowry method. Lipids were extracted
from homogenate by Bligh and Dyer method with some modifications
and cholesterol and triglycerides were measured by kits (BioSystems
S.A., Barcelona, Spain). Briefly, the homogenate were mixed with
chloroform and methanol (1:1:2) and centrifuged 10min at 3000g. The
lower organic phase was extracted and the lipid extract was dried at
55 °C under nitrogen atmosphere. The resultant residue was recon-
stituted in isopropanol and cholesterol and triglycerides were de-
termined.
2.6.2. Retroperitoneal adipose tissue measurements
The adipocytes were observed in fresh samples by a Nikon Eclipse
LV100NPOL microscope with a high-precision rotating stage and sizes
measurement with the NIS Element Software. Retroperitoneal adipose
area was measured with the ImageJ Sofware.
2.6.3. Interleukins measurement
The levels of Tumor Necrosis Factor-Alpha (TNF-α), Interleukin 10
(IL-10) and Interleukin 1 beta (IL-1β) were determined by ELISA kits in
plasma samples.
2.6.4. FRAP determination
The total antioxidant capacity of the plasma samples were assessed
by the FRAP method (Benzie & Strain, 1996). This method evaluates the
reduction of Fe (III) to Fe (II) by the plasma and measured the blue-
colored Fe (II)-TPTZ complex formed at 593 nm. The results are ex-
pressed as mM of Fe (II).
The ferric reducing antioxidant power (FRAP) was also measure-
ment in liver homogenates by the FRAP method.
2.6.5. Levels of GSH/GSSG ratio in liver
Reduced and oxidized glutathione ratio (GSH /GSSG ratio) was
measured in the liver by the method described by Griffith (1980) with
modifications. Briefly, the liver homogenates were mixed with DTNB,
NADPH and Glutathione reductase and the levels of total GSH (reduced
and oxidized) were evaluated measuring absorbance (410 nm) at 2min
intervals for 20min. Quantification of GSSG was performed following
GSH derivatization with 2-vinylpyridine, and GSH was estimated by
subtracting GSSG from total GSH. The results are expressed as GSH/
GSSG ratio.
2.6.6. Oxidative stress biomarkers
Indicators of biomolecular damage were analyzed in plasma and
liver samples: carbonyl groups (CG), malondialdehyde (MDA) and 8-
hydroxydeoxyguanosine levels (8OHdG).
Carbonyl groups were used to evaluate the level of protein damage
in the plasma samples. A previously reported method (Levine et al.,
1990) was used for the quantification of CG in the plasma. Briefly, 10 µl
of plasma or liver homogenate was mixed with 500 µl of DNFH (0.2%/
HCl 2M) and incubated 4 h at room temperature. Then, the derivatized
proteins were precipitated by incubation (15min, 4 °C) with 500 µl of
20% trichloroacetic acid (TCA) and centrifuged at 6000×g during
3min. The supernatants were discard and the pellets washed with
ethanol:etyl acetate (1:1). The pellets were reconstituted in 6M gua-
nidine (37 °C, 30min) and the absorbance was measured at 373 nm.
The results are expressed as µmoles of CG per mg of protein.
Plasma and liver MDA levels were assessed by HPLC-DAD following
a previously described method (Grotto et al., 2007) and evaluate the
lipid peroxidation. Briefly, a mix of 75 µl of plasma or liver homo-
genate, 25 µl of distilled water and 25 µl of 3M NaOH were incubated at
60 °C during 30min. Then, 125 µl of 6% H3PO4 and 125 µl of 0.8%
thiobarbituric acid (TBA) were added and incubated at 90 °C during
45min. Next, 50 µl of 10% sodium dodecyl sulfate (SDS) was added
following the extraction of the generated complex by incorporation of
300 µl of butanol and centrifugation at 3000×g during 10min. Fi-
nally, 20 µl of the supernatant was injected in the HPLC-DAD system
and the absorbance of the eluent was measured at 532 nm. An Agilent
1100 series HPLC system (Agilent Technologies) equipped with a diode
array detector (DAD) and a Spherisorb3® ODS2 reversed phase C18
(250mm×4.6mm,3 µm particle size; Waters Cromatografia, S.A.,
Barcelona, Spain) column were used. The mobile phase was a mixture
of Milli-Q water:methanol (1:1, v/v) with a 0.6ml/min of isocratic
flow. MDA levels were calculated by using calibration curves of stan-
dard TMP and they are expressed as µM of MDA per mg of protein.
For the determination of 8OHdG in plasma samples, 50 µl of plasma
was incubated with 10 µl of proteinase K (20mg/ml) at 37 °C during
1 h. Then, 60 µl of 4% acetonitrile/ 130mM sodium acetate/0.6 mM
sulfuric acid solution was added and incubated 40min at 37 °C. Next,
the samples were centrifuged at 13,000g during 5min and the super-
natant were injected in the HPLC-EC system. A 1260 Infinity Agilent
HPLC system (Agilent Technologies, California, USA) with the electro-
chemical detector DECADE II (Antec Scientific, NV Zoeterwoude, The
Netherlands) and a Agilent Eclipse Plus C18 (100mm×4.6mm,
3.5 µm particle size; Agilent Technologies) column were used for the
analysis of 8OHdG. 8OHdG levels were calculated by using calibration
curves of standard 8OHdG and they are expressed as µM of 8OHdG.
2.6.7. Microbiota analysis
Total DNA was isolated from the freezed-dried caecal samples
(6 mg) using the QIAamp Mini DNA kit (Qiagen, West Sussex, UK)
following the manufacturer‘s instructions. Eluated DNA was treated
with RNase and DNA quantification was assessed spectro-
photometrically by using NanoDrop (BioTek, Vermont, USA). qPCR was
used to analyze five groups of bacteria in the caecal samples: All bac-
teria, Bacteroides, Lactobacilli, Eubacterium rectale/Clostridium coccoides
and Clostridium leptum. The 16S rDNA specific primers used are listed in
Supplementary Table 3 (Hernández-Hernández et al., 2012). For All
bacteria, Bacteroides and Lactobacilli, PCR conditions included a first
step at 50 °C for 2min, followed by 95 °C for 10min for initial dena-
turing and 40 cycles of denaturing at 95 °C for 15 s, primer annealing at
60 °C for 1min and product elongation at 72 °C for 1min. For
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Eubacterium rectale/Clostridium coccoides and Clostridium leptum, PCR
conditions included a first step at 94 °C for 5min for initial denaturing
and 40 cycles of denaturing at 94 °C for 20 s, primer annealing at 50 °C
for 20 s and product elongation at 72 °C for 1min. The proper product
amplification was verified by melting curve analysis. The results were
obtained using calibration curves and are expressed as log copy number
per ng of DNA.
2.7. Data presentation and statistical analysis
The results were expressed as means ± standard deviation of in-
dependent samples. Statistical analysis was performed using
Statgraphics® Centurion XVI, version 16.2.04 (Statpoint Technologies,
Inc., Warranton, VA, USA). One-way analysis of variance (ANOVA),
using Fisher's least significant difference (LSD) test, was used to de-
termine significant differences between the different experimental
groups. A value of p < 0.05 was applied to all analyses.
3. Results
In the study, we evaluated the effect of the supplementation with
100mg of WP/kg/d on disorders associated with the obesity induced by
high-fat-diet in Wistar rats. Rats fed with a standard diet (SD) were used
a control group. Furthermore, in parallel, we evaluated other standard
control group supplemented daily with WP (data not shown) and not
differences with thea standard group (SD) were observed for all of the
parameters studied.
3.1. Energy intake and weight gain
High-Fat Diet (HF) increased energy intake in Wistar rats
(Supplementary Fig. 2A). Energy ingestion was higher in all groups of
HF rats from the beginning of the experiment compared with the
Standard Diet group (SD).
All groups increased their weight during the 14 weeks of experiment
and the HF group always had the highest weight (Supplementary
Fig. 2B). At the end of the study the body weights of rats fed with the
HF diet were significantly higher (54%) than those fed with the stan-
dard diet (Table 1). However, the HF rats that received the Wine
Product (HF+WP1w and HF+WP7w) showed a 23% and a 29% less
increased body weight than the HF that not ingested the WP. No sig-
nificant difference was observed between the HF+WP1w and HF-
WP7w groups.
3.2. Systolic blood pressure
After 14 weeks of study, HF diet was able to significantly cause an
elevation of systolic blood pressure (SBP) in rats of the HF group
(Table 1). Furthermore, the SBP was significantly different between SD
and HF groups until the 5th week (Supplementary Fig. 3). In contrast,
the ingestion of wine product by HF rats (HF-WP1w and HF-WP7w)
produced a significant reduction in their systolic blood pressure com-
pared with the HF group (Table 1 and Supplementary Fig. 3).
3.3. Blood glucose, cholesterol and triglyceride in plasma
The consumption of HF diet conduced to an increase in the levels of
blood glucose of about 27% compared with the standard fed rats
(Table 1). Interestingly, the WP intake reduced the blood glucose in the
HF rats.
The cholesterol levels in plasma increased in HF rats compared to
control group and the intake of the wine pomace product decreased the
levels (Table 1). No difference was observed between groups for the
triglyceride plasma levels (Table 1).
3.4. Lipid content in liver
Hepatic levels of cholesterol and triglyceride were increased in HF
rats (Table 1). Both WP groups (HF-WP1w and HF-WP7w) showed a
reduction of the cholesterol and triglyceride levels compared with the
HF group that not receive WP. With regard to the triglyceride, the re-
duction was more marked for the HF-WP7w group.
3.5. Organs weight
As observed in Table 1, the liver was the only organ whose weight of
HF rats was significant higher than the SD rats. The WP intake results in
a decrease of the weight of the liver and no changes were observed in
Table 1
Energy intake, weight gain, blood pressure and plasma and organ measurements at 14th week.
Control (SD) Obese (HF) Obese+ Product (HF+WP1w) Obese+Product 7w(HF+WP7w)
Energy Intake (kCal/d) 62.7 ± 4.7a 84.8 ± 17.0b 75.6 ± 17.4b 81.4 ± 13.9b
Weight Gain (g) 155 ± 6a 283 ± 39b 218 ± 22a 201 ± 30a
Systolic Blood Pressure (mmHg) 128 ± 5a 149 ± 4b 143 ± 14ab 136 ± 3ab
Plasma
Glucose (mg/dl) 111 ± 23a 153 ± 12c 140 ± 19bc 124 ± 14ab
Cholesterol (mg/dl) 74.7 ± 4.4a 97.0 ± 12.0b 85.6 ± 10.9ab 80.7 ± 10.7a
Triglycerides (mg/dl) 165 ± 22a 168 ± 22a 188 ± 49a 179 ± 43a
Liver Cholesterol (mg/g) 1.06 ± 0.20a 2.86 ± 0.39c 2.06 ± 0.45b 2.19 ± 0.06b
Liver Triglycerides (mg/g) 2.60 ± 0.21a 7.15 ± 1.10d 5.50 ± 0.58c 3.69 ± 0.43b
Organs (mg/mm)
Pancreas 13.0 ± 0.6a 15.4 ± 1.4ab 17.2 ± 1.2b 15.2 ± 1.6ab
Liver 211 ± 9a 270 ± 36b 246 ± 24ab 219 ± 14a
Kidney 43.5 ± 1.4a 43.8 ± 4.1a 45.3 ± 3.0a 43.5 ± 4.7a
Hearth 21.1 ± 1.9a 23.0 ± 2.9a 23.0 ± 4.3a 19.6 ± 0.4a
Intestine 59.6 ± 7.7a 69.4 ± 5.6a 69.5 ± 3.9a 66.8 ± 6.3a
Visceral fat weight
Mesenteric Fat 212 ± 17a 462 ± 18c 388 ± 3b 385 ± 152bc
Gonadal Fat 249 ± 31a 633 ± 15c 559 ± 29b 510 ± 222bc
Thoracic Fat 26.5 ± 1.1a 71.2 ± 0.4c 59.8 ± 4.8b 37.2 ± 13.5a
Perirenal Fat 250 ± 20a 644 ± 26c 444 ± 2b 560 ± 228bc
Total Fat 738 ± 64a 1809 ± 7c 1451 ± 20b 1492 ± 625bc
1Data are mean ± standard deviation of 5 independent samples.
2Significant differences (p < 0.05) between groups are indicated with latin letters.
3SD: standard diet fed rats; HF: high fat diet fed rats; HF+WP1w: High Fat diet+wine pomace product (WP) from the 1st week fed rats; HF+WP7w: High Fat
diet+wine pomace product (WP) from the 7th week fed rats.
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the other organs.
3.6. Abdominal adiposity, total fat, adipocyte area and visceral fat
As observed in Fig. 1(A and B), HF diet increased the retroperitoneal
adipose area compared with the standard diet in about 2.3 fold. How-
ever, the ingestion of WP produced a significant reduction in the fat
area as observed for the HF-WP1w and HF-WP7w groups. Furthermore,
the HF diet increased the area of mesenteric adipocytes (Fig. 1C and D)
and the adipocyte area of both HF-WP groups was similar than the SD
group. These results agree with the total mass of mesenteric tissue that
was lower for the SD, HF-WP1w and HF-WP7w (212mg/mm, 388mg/
mm and 385mg/mm) groups than the HF group (462mg/mm)
(Table 1). Furthermore, the weight of total visceral fat (mesenteric,
gonadal, thoracic and perirenal) was higher for the HF rats and the WP
intake reduced the visceral fat of rats (Table 1).
The consumption of HF diet exhibited fat tissue around the heart
(Fig. 1F). The weight of the fat observed in this organ was 19 fold times
more for the HF group compared with the SD group (Fig. 1E and F). The
ingestion of the WP with the HF diet reduced the fat heart in a 53% and
55% for the HF-WP1w and HF-WP7w groups, respectively. However,
not difference was observed in the hearth weight (Table 1). In another
hand, thoracic fat was significant lower for the SD and HF-WP1w
groups (Table 1).
3.7. Plasma inflammatory makers
Plasma levels of Tumor Necrosis Alpha (TNF-α) and Interleukin 1
beta (IL-1β) were increased in HF rats (Fig. 2A and B). The WP inges-
tion significantly reduced the plasma levels of both of these pro-in-
flammatory cytokines.
In contrast, the Interleukin 10 (IL-10) was reduced in the plasma of
HF rats. No significant changes were observed between HF and HF-WP
groups (Fig. 2C).
3.8. Biomarkers of oxidative stress
3.8.1. Antioxidant levels of plasma and liver
As observed in Fig. 3A, plasma antioxidant capacity assessed by
FRAP method was altered in rats fed the HF diet in comparison with the
SD diet rats. The SD rats had values of 0.5mM for FRAP while the HF
rats had 0.19mM. However, the intake of 100mg/kg of WP by the HF-
WP1w significantly increased the antioxidant capacity of the plasma a
42%.
A similar effect was observed in the redox environmental in the liver
of rats fed with the WP. Both HF-WP1w and HF-WP7w increased the
liver antioxidant capacity measured by FRAP and the levels of GSH/
GSSG ratio compared with the HF group (Fig. 3B and C).
3.8.2. Plasma and liver biomarkers of oxidative stress
In plasma, three types of biomarkers of oxidative stress were eval-
uated: carbonyl groups (CG) as biomarker of protein damage (Fig. 4A),
malondialdheyde (MDA) for lipid peroxidation asses (Fig. 4B) and 8-
hydroxydeoxyguanosine (8OHdG) levels as indicator of DNA damage
(Fig. 4C).
All three markers were increased for the HF while the WP reduced
the plasma levels of GC, MDA and 8OHdG for both groups (HF-WP1w
and HF-WP7w).
In liver, both CG and MDA levels was higher for the HF rats (Fig. 4D
and 4E). The intake of WP conduced to a reduction of the CG and MDA
levels in liver reaching similar levels to the SD group.
3.8.3. Microbiota changes in the caecal content
As observed in Table 2, the amount of total bacteria was increased
Fig. 1. Fat determinations. Abdominal fat area, adipocyte size and heart fat were determined by triplicate. (A) Bar graph of abdominal fat area calculated with
ImageJ software. (B) Abdominal fat images. (C) Bar graph of adipocyte size measurement by microscopy. (D) Adipocytes images. (E) Bar graph of heart adipocity
deposition assessed by ImageJ software. (F) Heart fat images. Significant differences (p < 0.05) between groups (n= 5) are indicated with latin letters. SD: standard
diet fed rats; HF: high fat diet fed rats; HF+WP1w: High Fat diet+wine pomace product (WP) from the 1st week fed rats; HF+WP7w: High Fat diet+wine
pomace product (WP) from the 7th week fed rats.
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for the HF group compared with the SD group. Although the supple-
mentation with the WP did not established any significant reduction
with respect to the total content.
High fat diet (HF) also increased Bacteroides and decreased
Lactobacillus, as showed Table 2. Not significant differences were ob-
served for Eubacterium rectale/Clostridium coccoides and Clostridium
leptum groups between SD and HF fed rats.
The WP intake after 7th week of HF diet ingestion (HF+WP7w)
conduced to a significant reduction in the content Bacteroides and
Eubacterium rectale/Clostridium coccoides.
In addition, the WP intake increased the amount of Lactobacillus
spp. in the HF-WP1w and HF-WP7w groups.
4. Discussion
Many studies showed that the intake of high fat diets to model
obesity in rodents conduced to several disorders in the animals that
resemble the human metabolic syndrome and their cardiovascular
complications (Buettner et al., 2006). In the present study, the animals
fed with the high fat diet gained more weight, had higher plasma glu-
cose, cholesterol and triglycerides levels, and showed elevated systolic
blood pressure. These results are expected and they agree with other
studies where the intake of high fat diets with lard as fat source con-
duces to a pronounced obesity and insulin resistance (Buettner et al.,
2006).
Several studies have evaluated the impact of polyphenols in the
development of obesity (Jin, Song, Weng, & Fantus, 2018; S. Wang
et al., 2014; Zhao et al., 2017). It is established that obesity is a
multifactorial condition of chronic inflammation and oxidative stress
(Wang et al., 2014). Therefore, the antioxidant and anti-inflammatory
effects of the wine pomace product through radical scavenging and
signaling pathways modulation (SIRT1, AP1, NF-κB), demonstrated in
previous works (Gerardi et al., 2019; Del Pino-García, Gerardi et al.,
2016), could be an important strategy against obesity-related in-
flammation. In this aspect, the intake of the wine pomace product (WP)
by the high-fat fed rats reduced the alterations of the parameters
mentioned above (body weight, plasma glucose, cholesterol and tri-
glycerides, and blood pressure), possible due its high content in fiber
and polyphenols such as resveratrol, epigallocatechin and phenolic
acids (Del Pino-García, Gerardi et al., 2016; Del Pino-García, González-
Sanjosé et al., 2016; Zou et al., 2018).
Surprisingly, the supplementation with 100mg/kg of WP reduced
the energy intake by the SD rats in a 19% (data not shown). However,
this reduction was not accompanied by a reduction in the body weight
compared with the SD group. This fact would indicate that the WP
ingestion contributes to the satiation, probably by their fiber content,
but this is not sufficient to have an impact in the body weight. Manna
and Jain (2015) commented that dietary fibers increase postprandial
satiety and decrease hunger in short-term studies.
Accumulation of excessive fat in adipose tissue and other organs
leads to metabolic changes that increase the risk of morbidity in obese
individuals. One of the organs that are affected by the deposition of fat
is the liver and this is associated with a major risk of fatty liver disease
(Aoun et al., 2010). This disease is characterized by an accumulation of
lipids in the hepatocytes known as hepatic steatosis and posterior he-
patocyte injury, inflammation and fibrosis (cirrhosis) in which
Fig. 2. Inflammatory Markers. Plasma levels of Tumor Necrosis Alpha (A),
Interleukin 1 beta (B) and Interleukin 10 (C) determined by ELISA assays by
triplicate. Significant differences (p < 0.05) between groups (n=5) are in-
dicated with latin letters. SD: standard diet fed rats; HF: high fat diet fed rats;
HF+WP1w: High Fat diet+wine pomace product (WP) from the 1st week fed
rats; HF+WP7w: High Fat diet+wine pomace product (WP) from the 7th
week fed rats; TNF-α: Tumor Necrosis Alpha; IL-1β: Interleukin 1 beta; IL-10:
Interleukin 10.
Fig. 3. Antioxidant Status. Antioxidant capacity of the plasma samples assessed
by FRAP method (A), cell redox environment in liver evaluated by reduced/
oxidize glutathione (GSH/GSSG) ratio (B) and liver FRAP levels (C). All mea-
surements were performed in triplicate. Significant differences (p < 0.05)
between groups (n=5) are indicated with latin letters. SD: standard diet fed
rats; HF: high fat diet fed rats; HF+WP1w: High Fat diet+wine pomace
product (WP) from the 1st week fed rats; HF+WP7w: High Fat diet+wine
pomace product (WP) from the 7th week fed rats.
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oxidative stress plays an important role. In our study, the liver weight
and their cholesterol and triglycerides levels were increased by the high
fat diet. Nerveless, the ingestion of the WP reduced the liver weight and
the levels of lipids in this organ. The content of polyphenols and fiber in
the WP explains this protective effect of the WP in the liver metabolism.
Wine pomace product (WP) act on lipid metabolism by modulating
desaturase activity (gene expression and activity) and signaling path-
ways of lipid synthesis and degradation (Aoun et al., 2010; Feillet-
Coudray et al., 2009) including activation of sirtuin-1 deacetylase
(SIRT1) as we saw in previous studies in culture cells (Gerardi et al.,
2019). Furthermore, in previous works of our group we demonstrated
that the WP modulates the Keap1-Nrf2-ARE system, an important an-
tioxidant signaling pathway that regulates the lipid metabolism-related
genes (Gerardi et al., 2019; Tu, Wang, Li, Liu, & Sha, 2019). In addition,
polyphenols presents in WP can also inhibit the absorption of fatty acids
(Xu et al., 2015) and this contribute to the reduction in the lipids levels
(plasma and liver) on the body observed for the rats that intake the WP.
On the other hand, it is known that short-chain fatty acids (SCFAs) from
fiber microbiota metabolism act as signaling molecules regulating dif-
ferent biological processes (Koh, De Vadder, Kovatcheva-Datchary, &
Bäckhed, 2016), the expression of different genes involved in the pro-
duction of pro-inflammatory agents (Johnstone, 2002; Koh et al., 2016;
Brooks et al., 2017) and modulates glucose and lipid metabolism
through microbiota composition regulation (Makki, Deehan, Walter, &
Bäckhed, 2018; Bäckhed et al., 2004). In previous studies, we observed
that the intake of WP by Wistar rats leads to the increase of the butyric
acids levels and the decrease of acetic acid levels in fecal samples (Del
Pino-García et al., 2017) that could explain the results obtained. In this
regards, the decrease in glucose, cholesterol and triglycerides levels in
plasma was more marked in the WP rats at the seven week when they
already showed altered parameters associated with the established
obesity. These results suggest a potential effect of WP in the ameli-
oration of the metabolic disorders of obesity more than in the preven-
tion of its development.
Besides the accumulation of fat in liver, the increased abdominal fat
observed for the high fat diet fed rats also are an important factor of risk
in obesity. The adipose tissue acts as an endocrine organ that produce
pro-inflammatory cytokines and, more precisely, adipokines produced
principally in the abdominal fat, that regulate energy homeostasis, in-
flammation and insulin resistance (Seymour et al., 2009). Therefore, a
Fig. 4. Biomarkers of oxidative stress in plasma and liver samples. Plasma carbonyl groups (A), malondialdehyde (B) and 8-hydroxydeoxyguanosine levels (C). Liver
carbonyl groups (D) and malondialdehyde (E). All measurements were performed in triplicate. Significant differences (p < 0.05) between groups (n= 5) are
indicated with latin letters. MDA: malondialdehyde; 8OHdG: 8-hydroxyguanosine; SD: standard diet fed rats; HF: high fat diet fed rats; HF+WP1w: High Fat
diet+wine pomace product (WP) from the 1st week fed rats; HF+WP7w: High Fat diet+wine pomace product (WP) from the 7th week fed rats.
Table 2
Microbiota composition in caecal samples of rats fed with SD, HF and HF+WP assessed by qPCR.
Control (SD) Obese (HF) Obese+Product (HF+WP1w) Obese+ Product 7w (HF+WP7w)
All bacteria 9.85 ± 0.15a 10.06 ± 0.10b 10.06 ± 0.03b 9.99 ± 0.10ab
Bacteroides spp. 10.19 ± 0.06a 10.78 ± 0.26c 10.83 ± 0.09c 10.52 ± 0.10b
E. rectale/C. coccoides 9.65 ± 0.13a 9.71 ± 0.09b 9.87 ± 0.09b 9.54 ± 0.06a
C. leptum 10.02 ± 0.11a 10.01 ± 0.12a 10.01 ± 0.10a 10.00 ± 0.16a
Lactobacillus spp. 10.54 ± 0.26b 8.94 ± 0.45a 10.58 ± 0.22b 9.88 ± 0.30b
1Results are expressed as log10 copy number/ng DNA.
2Data are mean ± standard deviation of 5 independent samples.
3Significant differences (p < 0.05) between groups are indicated with latin letters.
4SD: standard diet fed rats; HF: high fat diet fed rats; HF+WP1w: High Fat diet+wine pomace product (WP) from the 1st week fed rats; HF+WP7w: High Fat
diet+wine pomace product (WP) from the 7th week fed rats.
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reduction of the abdominal fat contributes in the amelioration of the
obesity complications by decreasing the adipokines and their pro-in-
flammatory effects. In the current study, wine pomace ingestion was
associated with significantly reduced abdominal fat. Previous studies
demonstrated that diet enriched with anthocyanin reduced glucose,
insulin and triglyceride and increased liver and fat tissue expression of
PPAR-γ, PPAR-α and lipoprotein lipase (Park, Lee, & Ma, 2005).
Seymour et al. (2009) associated the increased liver PPAR-α mRNA
with reduced liver lipid content, enhanced hepatic acyl-coenzyme A
oxidase activity, and reduced fatty acid synthase activity. In our study,
the effect of the WP in the reduction of the abdominal fat area may be a
consequence of these PPAR-α-related mechanisms. Remarkably, the WP
ingestion attenuates the fat abdominal accumulation when it was ad-
ministrated both from the first week and from the seven week, sug-
gesting a beneficial effect in both the development and amelioration of
the obesity-related abdominal fat.
The size of the adipose cells, the adipocytes, is another important
aspect of the inflammatory process in the obesity. Adipocytes are re-
sponsible of the production of several cytokines such as TNF-α and IL-6
that regulate the synthesis of fatty acids and their oxidation, and
modulates the insulin sensitivity. Therefore, the higher adipocyte size
observed for the high fat diet will contribute with the inflammatory
process while the reduced size observed for the WP intake could im-
prove this pathology. Both, polyphenols and dietary fiber metabolites
(SCFAs) have demonstrated anti-lipolysis action reducing adipocyte
size. In addition, the PPAR-α activation by certain polyphenols reduces
adipocyte size conducing to a less secretion of inflammatory cytokines
and increases the inhibition of NF-κB transcription factor (Seymour
et al., 2009). In previous studies we observed a downregulation of the
NF-κB pathway by the WP (Gerardi et al., 2019). In this sense, con-
sidering that NF-κB increases the generation of adipokines by the adi-
pose tissue, the WP inhibition of this pro-inflammatory pathway could
contribute to the reduction of the adipocyte pro-inflammatory action.
The observed increase of the pro-inflammatory cytokines TNF-α and IL-
1β in plasma of the HF rats, possibly induced by the NF-κB, supports the
existence of an inflammatory state in the obese rats that is prevented by
the WP intake. Thus, the inhibitory effect of the WP in the expression
and activation of NF-κB observed in previous studies (Gerardi et al.,
2019), may be responsible of the reduced levels of these pro-in-
flammatory cytokines in the WP fed rats. Furthermore, it had been
demonstrated that the microbial metabolism of the dietary fiber leads
to the release of the ferulic acid present in different sources of fiber and
polyphenols such as the wine pomace and this ferulic acid have anti-
inflammatory action reducing the production of pro-inflammatory cy-
tokines (Sadar, Vyawahare, & Bodhankar, 2016). In contrast, inter-
leukine-10 (IL-10), an anti-inflammatory cytokine responsible of the
limitation and termination of the inflammatory response (Febbraio,
2014), was reduced in the plasma of HF rats. These agrees with other
works in which the IL-10 was reduced in serum of obese individuals
playing an important role in the obesity-related inflammation of several
organs (Kondo, 2018). With regard to the adipocytes, it has been de-
monstrated that some polyphenols have a role in the differentiation and
proliferation of the adipose cells. In particularly, an anti-obesity action
has been observed for epigallocatechin gallate (EGCG), a type of
polyphenol of the WP. Several studies suggested that EGCG inhibits pre-
adipocyte differentiation, decreases adipocyte proliferation, induces
adipocyte apoptosis, suppress lipogenesis, and promotes lipolysis and
beta (β)-oxidation (Wang et al., 2014). The exposure of high fat diet fed
mice to polyphenol extract decreased adipocyte proliferation, differ-
entiation and size through the decreasing expression of PPARγ, SREBP-
1 and FAS transcription factors (Trindade et al., 2019). Thus, the
modulatory effect of the WP polyphenols could contribute to the re-
duction in the size of the rat WP fed adipocytes.
Obesity is considered a risk factor for cardiovascular disease and
heart failure. Accumulation of lipids in the cardiac tissue results in
cardiac dysfunction as consequence of lipotocixity where the lipids
cause oxidative stress, inflammation, mitochondrial dysfunction and
endoplasmic reticulum stress, apoptosis, and abnormal myofibrillar
function (Manley, 2013). In the current study, fat tissue was increased
in the hearth of rats fed with the high fat diet. Excessive epicardial fat is
common in obesity and has a strong relationship with visceral adip-
osity. This agrees with our results in which the total visceral fat mass
was increased by the high fat diet. In contrast, the WP intake prevents
the risk of cardiac dysfunction by reducing the fat deposit around the
hearth along with the reduction in the systolic blood pressure. Many
studies suggested that resveratrol, a stilbene present in the WP, has
anti-obesity action and reduction of the adipose tissue by down-
regulation of PPARγ through indirect activation of SIRT1 and FOXO1
(Costa et al., 2011).
The excessive accumulation of fat in the organs stimulates pro-
oxidant and pro-inflammatory states. Obesity induces systemic oxida-
tive stress through several mechanisms including superoxide produc-
tion from NADPH oxidases, oxidative phosphorylation, protein kinase C
(PKC) activation, decreased antioxidant defenses, postprandial ROS
generation, chronic inflammation and polyol and hexosamine pathways
induction (Feillet-Coudray et al., 2009; Manna & Jain, 2015). Ferric
reducing antioxidant power (FRAP) has been used to evaluates the ra-
dical quenching capacity by the plasma antioxidants. In agree with
others studies, we reported lower plasma levels of FRAP in obese rats
(HF) compared with standard fed rats (SD) (Vincent & Taylor, 2006).
This increased oxidative stress in obese rats is a consequence of its as-
sociated plasma free fatty acids elevation that promotes the generation
of superoxide radical through PKC activation of the endothelial NADPH
oxidase, and the decreased expression and activities of antioxidant
enzymes by obesity (Manna & Jain, 2015). ROS reduction and induc-
tion of the antioxidant systems are related with the increase of the
antioxidant capacity of the plasma by polyphenols. The increased an-
tioxidant capacity of the plasma (TAC) of WP-fed rats agrees with
several studies that found significant elevations in plasma TAC after
consumption of polyphenol-rich foods such as fruits and vegetables, tea,
and red wine (Wang, Chun, & Song, 2013). Several studies demon-
strated that high fat diets in rats modified the hepatic mitochondrial
capacity. Excessive energy substrate causes mitochondrial dysfunction
increasing ROS production and altered redox homeostasis (Feillet-
Coudray et al., 2009). Considering that glutathione represents an an-
tioxidant system that provides reducing equivalents for the reduction of
H2O2 and lipid hydroperoxides by glutathione peroxidase in liver, the
observed reduction of glutathione in liver of HF rats reflects a pro-
oxidant environment in this organ as consequence of the HF diet. This
also agrees with the lower FRAP levels observed in the liver of the HF
rats. In contrast, this pro-oxidant environment was reduced by the WP
ingestion as result of the antioxidant and anti-obesity effects of the WP
polyphenols. This antioxidant effect can be attributed to the presence of
anthocyanins, flavanols and flavonols, including catechin and quer-
cetin, which may have different mechanisms of action against glu-
tathione. First, the antioxidant capacity of polyphenols reduce the
amount of endogenous antioxidants such as GSH, used to offset the pro-
oxidant environmental. In addition, some polyphenols present in grape
skins can increase the expression of γ-glutamyl-cysteine synthetase,
whose function is to synthesize glutathione. Similar results were ob-
tained in the investigations of Hsu and Yen (2007) in which gallic acid
administered to obese rats demonstrates a reduction in GSSG levels, and
increases the GSH/GSSG ratio (Hsu & Yen, 2007).
Vincent and Taylor (2006) observed a siginificant correlation be-
tween obesity and oxidative stress biomarkers. Weight reduction in-
creases antioxidant defenses, decreases oxidation biomarkers and re-
duces obesity-related complications. The increased damage for the HF
group, showed by the highest levels of oxidative biomarkers, agrees
with the lowest antioxidant capacity of the HF plasmas. The antioxidant
compounds present in the WP was able to prevent plasma biomolecular
damage by reducing the plasma levels of GC, MDA and 8OHdG. Similar
results was observed in the liver where the highest damage of proteins
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and lipids is a consequence of the lower antioxidant environment ob-
served in the liver of HF rats. Mitochondria and NADPH oxidase sys-
tems are the principal source of ROS. However, Feillet-Coudray et al.
(2009) showed that the increased oxidative stress in liver from obesity
rats mainly results from the increased mitochondrial ROS production. It
is to be expected that a higher production of ROS have deleterious ef-
fects by irreversible oxidation of lipids, proteins and DNA. The intake of
WP conduced to a reduction of both lipid and protein damage. In agree
with other authors (Feillet-Coudray et al., 2009), polyphenols supple-
mentation prevented the lipid and protein oxidation induced in liver by
the HF diet, probably by acting directly as ROS scavengers or by sti-
mulating endogenous antioxidant systems. These results showed a
protective effect against oxidative damage in the liver of obese rats.
The diet plays an important role in the composition of the gut mi-
crobiota (Flint, Scott, Louis, Duncan, & Abstract, 2012). There is a close
relationship between the host and the microorganisms that colonize it,
which can be both beneficial and harmful depending on the majority
groups that composite it and their metabolic activity. The gut micro-
biota provides essential nutrients and prevents the development of
pathogens, which maintains the immunity of the intestinal mucosa and
the metabolism of fats. Several studies show that high fat diet causes
changes in the composition of the microbiota facilitating the develop-
ment of harmful microorganisms that produce endotoxins and alter the
metabolism of beneficial bacteria such as Bifidobacteria (Yang et al.,
2019). These changes can be associated with an increase in bacteria
that degrade indigestible polysaccharides allowing their intestinal ab-
sorption and conducing to the generation of energy from substances
that normally are eliminated by the feces. Thus, there is a specific mi-
crobiota that is capable of obtaining more energy from the same daily
caloric intake (Tinahones, 2017). The results showed that Bacteroides, a
group of highly pathogenic bacteria and related resistance to anti-
biotics, were incremented by the high fat diet. The modulation of mi-
crobiota by our WP its agree with other studies in which observed that
some polyphenols present in the WP, significantly reduced Bacteroides
spp. growth and enhanced the total bacterial number (Ozdal et al.,
2016). Similar results were found in other studies where a decrease of
Bacteroides was observed in obese rats supplemented with sinapic acid
and resveratrol (Yang et al., 2019). Dietary fiber also produces shifts in
the microbiota composition by allowing the proliferation of microbial
species that are able to utilize this fiber as substrates (primary de-
graders) such as Firmicutes or those species that benefit from the car-
bohydrate breakdown products (secondary degraders) (Makki et al.,
2018). The change in the population of Bacteroides due to the effect
wine pomace bioactive compounds reduces the risk of inflammation
and resistance to antibiotics; therefore it can contribute to an im-
provement in the intestinal health of individuals. In contrast, Lactoba-
cillus spp., a group of beneficial bacteria, was reduced in the HF rats
while the WP ingestion incremented the amount of this bacteria. Si-
milar studies reveal positive effects of the supplement with grape, since
they increased the populations of beneficial bacteria of Lactobacillus and
Bifidobacterium (Requena et al., 2010). Some of wine pomace bioactive
compounds including fiber or polyphenols such as flavanols, antho-
cyanins and stilbens, promoted the growth of Lactobacillus inducing
changes in the gut microbiota and positively selection for beneficial
microbes (Nicolucci et al., 2017; Ozdal et al., 2016; Zou et al., 2018).
Furthermore, the acidification of the intestinal environment by SCFAs,
as product of microbiota fiber fermentation, increase the absorption of
ions with antimicrobial action (Baye, Guyot, & Mouquet-Rivier, 2017;
Makki et al., 2018) that could contributing to the reduction of some
species such as Bacteriodes. In general, there has been a decrease in the
groups of harmful bacteria and an increase in those that have a bene-
ficial effect on the organism, which suggests a possible prebiotic effect
of the product derived from the red wine pomace.
In summary, the positive effects of the wine pomace product on the
obesity, obesity-induced inflammation, and metabolic syndrome are
illustrated by the significantly reduced body weight, abdominal fat
area, lower blood glucose, decreased liver weight and lipids deposition,
and lower adipocyte size. These anti-obesity effects are associated with
a reduction of the oxidative stress in the organism and an improvement
of the healthy/harmful microbiota composition. As rich source of
polyphenols and fiber, wine pomace product introduced in the diet may
modify and reduce several risk factors of obesity complications. Further
studies are needed in human subjects with obesity that evaluates the
clinical benefits.
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